Presentations

Documents

Order by : Name | Date | Hits [ Descendent ]

Current epidemiological trends in the West, East and developing countries Current epidemiological trends in the West, East and developing countries

hot!
Date added: 01/18/2017
Date modified: 01/18/2017
Filesize: 256 Bytes
Downloads: 2524

Oral presentation given by UMC at the EASL Monothematic Conference, Riga, Latvia, 12th – 14th May 2016

Defining a Clinically Meaningful Change in Circulating Biomarker, Imaging and Elastography Based... Defining a Clinically Meaningful Change in Circulating Biomarker, Imaging and Elastography Based...

hot!
Date added: 04/11/2019
Date modified: 04/11/2019
Filesize: 256 Bytes
Downloads: 1237

"Defining a Clinically Meaningful Change in Circulating Biomarker, Imaging and Elastography Based Assessment of Pre-cirrhotic NASH"

Invited presentation given by UNITO at AASLD/EASL NAFLD Endpoints Conference, Alexandria, VA, USA, 30th June 2018

Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection

hot!
Date added: 07/28/2018
Date modified: 07/28/2018
Filesize: 256 Bytes
Downloads: 1491

"Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection and Staging of Advanced Non-Alcoholic Fatty Liver Disease in a Large International Multi-Centre Patient Cohort"

Oral presentation given by UNEW, ICAN, UMC, UNITO & NB at the BASL Annual Meeting, Coventry, UK, 20th September 2017

Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for... Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for...

hot!
Date added: 08/05/2018
Date modified: 08/05/2018
Filesize: 256 Bytes
Downloads: 1452

"Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection and Staging of Advanced Non-Alcoholic Fatty Liver Disease in a Large International Multi-Centre Patient Cohort"

Oral presentation given by UNEW, ICAN, UNITO, UMC & NB at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Diabetes and NAFLD: Common pathophysiological mechanisms Diabetes and NAFLD: Common pathophysiological mechanisms

hot!
Date added: 01/18/2017
Date modified: 01/18/2017
Filesize: 10.97 MB
Downloads: 1401

Oral presentation given by CNR at the EASL International Liver Congress, Barcelona, Spain, 13th – 17th April 2016

Diabetes and NAFLD: Two sides of the same coin Diabetes and NAFLD: Two sides of the same coin

hot!
Date added: 05/22/2016
Date modified: 05/22/2016
Filesize: 8.04 MB
Downloads: 1861

Oral presentation given by CNR at the 12th Portuguese Congress on Diabetes, Faro, Portugal, 17th - 20th March 2016

Diagnosis and natural history: What should the hepatologist know about diabetes Diagnosis and natural history: What should the hepatologist know about diabetes

hot!
Date added: 01/18/2017
Date modified: 01/18/2017
Filesize: 256 Bytes
Downloads: 2525

Oral presentation given by CNR at the EASL Monothematic Conference, Riga, Latvia, 12th – 14th May 2016

Diagnostic tools to assess fibrosis in practice and clinical trials Diagnostic tools to assess fibrosis in practice and clinical trials

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 1307

Oral presentation given by UMC at Digestive Disease Week (DDW), Washington DC, USA, 2nd - 5th June 2018

Dietary counselling focusing only on fructose consumption improves hepatic inflammation in... Dietary counselling focusing only on fructose consumption improves hepatic inflammation in...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.94 MB
Downloads: 1043

"Dietary counselling focusing only on fructose consumption improves hepatic inflammation in patients with NAFLD - a prospective, controlled, randomized open-label study (NUCES NASH)"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a... Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.91 MB
Downloads: 986

"Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a model of non-alcoholic fatty liver disease (NAFLD)"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017